3D Cell Culture Market Overview:
The Global 3D Cell Culture Market accounted for $765 million in 2015, and is anticipated to reach $4,691 million by 2022, registering a CAGR of 29.4% from 2016 to 2022.
3D cell culture is an in vitro technique where cells grow in an artificially created environment, which resembles the in vivo environment. This technique stimulates normal cell to differentiate, proliferate, and migrate by interacting with their three-dimensional surroundings.
The homotypic and heterotypic 3D tissue culture models mimic the physiologic, histologic, and functional properties of the respective tissues. These properties influence different cellular functions such as adhesion, migration, gene expression, and proliferation. Normal polarization and differentiation of epithelial cells are important for the formation of duct-like structures in in vitro conditions, which can be achieved when the cells are cultivated in 3D cultures. Moreover, the synergistic effect required for the interactions of cell-cell and cell-extracellular matrix (ECM), which can control the expression of molecules involved in cell differentiation, is achieved in 3D cell cultures.
The report analyzes the 3D cell culture market into four segments, namely, product type, applications, end users, and geography. By product type, the market is segmented into scaffold-based platforms, scaffold-free platforms, gels, bioreactors, microchips, and services. Scaffold-based platforms are further segmented into macro-porous, micro-porous, nano-porous, and solid scaffolds. Applications covered in the study include cancer, stem cell research, drug discovery, and regenerative medicine. On the basis of end user, the market is categorized into biotechnology & pharmaceutical companies, contract research laboratories, and academic institutes. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The 3D cell culture market is driven by increased investment in healthcare, R&D, and other research-related activities. The novel concept of customized 3D cell culture products has allowed small companies to enter the market. Large-sized companies have focused on product launch to cater to the specific requirements of the researchers. For instance, Thermo Fisher Scientific collaborated with Applikon Biotechnology and launched two new single-use bioreactor controller platforms-i-Control and ez-Control.
The key players in the industry have adopted agreement and partnership as the developmental strategies to strengthen their market foothold. For instance, Lonza Group Ltd. signed an agreement with TAP Biosystems to distribute the former’s RAFT 3D cell culture system, which helped Lonza to expand its presence in the global market. This culture system is used by researchers to create physiologically similar cell culture models for drug discovery and development.
The key players profiled in this report include 3D Biotek, LLC; Advanced Biomatrix, Inc.; Becton, Dickinson and Company; Corning Incorporated; Kuraray Co., Ltd.; Lonza Group Ltd.; Merck & Co., Inc.; Synthecon, Incorporated; Thermo Fisher Scientific Inc.; and VWR Corporation. Other players in the 3D cell culture market include Global Cell Solutions, Inc., InSphero AG, Nanofiber Solutions, and Tecan Trading AG.
GLOBAL 3D CELL CULTURE MARKET REVENUE, BY REGION ($MILLION), 2014-2022
Asia-Pacific possesses high market potential for the 3D cell culture market owing to rise in demand for drug discovery and increase in focus on biotechnology industry. Moreover, low operating costs of industries & laboratory setups and rise in government investments for healthcare due to increased risk of diseases such as cancer boost the market growth. Various government organizations and private companies, and pharmaceutical and analytical instrumental companies have largely invested in the 3D cell culture projects to meet the demand of the novel drug discoveries and organs development.
REPUBLIC OF SOUTH AFRICA 3D CELL CULTURE MARKET ($MILLION), 2014-2022
The 3D cell culture market in Republic of South Africa is projected to grow at a CAGR of 28.4% during the forecast period. Increase in focus of the key players on the emerging markets such as Asia-Pacific and LAMEA contributes toward the growth of the market. This is attributed to the low investments required to set up and operate an industry in these regions.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis of the current and future trends from 2014 to 2022, which helps to identify the prevailing market opportunities.
- The market estimations are based on high-end analysis of the key developments.
- The market scenario is comprehensively analyzed with respect to the product type, applications, end users, and geography to assist in strategic business planning.
- The key market players within the 3D cell culture market are profiled in this report and their strategies are thoroughly analyzed, which help to understand the competitive market scenario.
3D CELL CULTURE MARKET KEY SEGMENTS
By Product Type
- Scaffold-Based Platforms
- Macro-Porous Scaffolds
- Micro-Porous Scaffolds
- Nano-Porous Scaffolds
- Solid Scaffolds
- Scaffold-Free Platforms
- Cancer Research
- Stem Cell Research
- Drug Discovery
- Regenerative Medicine
By End User
- Biotechnology & Pharmaceutical Companies
- Contract Research Laboratories
- Academic Institutes
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- Republic of South Africa
- Rest of LAMEA